Project Details
Description
An Open-Label Clinical Study Evaluating the Long-Term Safety of ALTU-135 Treatment of Patients with Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
| Status | Finished |
|---|---|
| Effective start/end date | 5/2/07 → 12/31/08 |
Funding
- ALTUS PHARMACEUTICALS INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.